Celgene's Shareholders, Not Bristol-Myers Squibb's, Should Reject The Deal [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
Celgene's Shareholders, Not Bristol-Myers Squibb's, Should Reject The Deal Summary Proposed deal deeply undervalues Celgene, and BMS admits it. Celgene’s pipeline is about to turn a corner with potentially 5 product launches in the next 2 years. Bristol-Myers Squibb has a poor and shallow pipeline and offers little in value to Celgene. Celgene shareholders should vote against the acquisition. When Celgene ( CELG BMY mega-merger letter to all BMS shareholders Since the merger announcement, the primary focus seems to be whether this is a good deal for BMS. And this is not without reason. Current BMS shareholders will be heavily diluted and be forced to take on not only $32 billion in new debt, but also $20 billion in assumed debt from Celgene. It also erases any chance of being BMS being acquired itself, a very real possibility considering rumors of a takeover have swirled since 2017. While these are real concerns, little debate has been raised over whether it is the right deal for Celg
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat [Yahoo! Finance]Yahoo! Finance
- Why Bristol Myers Squibb Stock Is Sinking Today [Yahoo! Finance]Yahoo! Finance
- Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 4/25/24 - Miss
BMY
Sec Filings
- 4/25/24 - Form 10-Q
- 4/25/24 - Form 8-K
- 4/22/24 - Form DEFA14A
- BMY's page on the SEC website